Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now

Search Results for "MFL":

Results: 25

Quotes

MFLX First Trust Flexible Municipal High Income ETF ETF - NASDAQ etf MFLTY Missfresh Ltd ADR Stock - NASDAQ equities MFLJ Metrofile Stock - Johannesburg equities MFLI MFL India Ltd Stock - BSE equities MULT Multi Finance PLC Stock - Colombo equities MATC Matco Foods Ltd Stock - Karachi equities MFLDX Cromwell Marketfield Long Short Fund Class Institutional Fund - US Funds fund MFLLX Morgan Stanley Institutional Fund, Inc. Inception Portfolio Class R6 Fund - US Funds fund
Show all (8)

News

BlackRock declares monthly distribution on Funds
By Seeking Alpha

BlackRock Municipal Target Term Trust (NYSE:MUE) - of $0.0640. BlackRock MuniHoldings Fund II (NYSE:MUH) - of $0.0745. Payable Aug. 1; for shareholders of record July 14; ex-div July 12. ...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.29%
By Investing.com

Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Oil & Gas sectors led shares lower. At the close in NYSE, the NASDAQ Composite index declined 3.25%. The best...

Chinese pitch big M&A break-up fees, small stakes to allay U.S. regulatory fears
By Reuters

By Denny Thomas HONG KONG (Reuters) - Chinese companies are offering to pay record break-up fees and are willing to settle for minority stakes in U.S. mergers and acquisitions in an attempt to...

Show all (5)

Analysis

Exposed: The 6% Dividend The IRS Doesn’t Want You To Buy
By Michael Foster

This levitating market just might have you thinking there are no more cheap 6%+ dividends out there. Well, don’t worry, because there certainly are—particularly if you fish in the obscure...

Flex (FLEX) To Divest Interests In Multek Operation To MFLEX
By Zacks Investment Research

Flex Ltd. (NASDAQ:MU) and NVIDIA Corporation (NASDAQ:NVDA) , both sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Long-term earnings...

Celyad: First “Clinical Validity” For NKR CAR T-Cells
By Edison

Celyad SA (NASDAQ:CYAD) has reported a complete morphological leukaemia-free status (MFLS) response in acute myeloid leukaemia (AML) in the NKR CAR T-cell THINK study. Given that spontaneous remission...

Show all (12)
Results: 8

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 5

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 12

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email